Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
ZYMEZymeworks	$1.80bn	n/a	n/a
INBXInhibrx	$1.79bn	n/a	n/a
DFTXDefinium Therapeutics	$1.78bn	n/a	n/a
PHVSPharvaris NV	$1.78bn	n/a	n/a
AMAMAmbrx Biopharma	$1.76bn	n/a	n/a
DVAXDynavax Technologies	$1.76bn	295.24	n/a
AGIOAgios Pharmaceuticals	$1.72bn	n/a	n/a
RLAYRelay Therapeutics	$1.72bn	n/a	n/a
RAPTRapt Therapeutics	$1.68bn	n/a	n/a
CAPRCapricor Therapeutics	$1.66bn	n/a	n/a
ANABAnaptysBio	$1.65bn	n/a	n/a
SIONSionna Therapeutics	$1.63bn	n/a	n/a
SLNOSoleno Therapeutics	$1.55bn	76.88	n/a
RXRXRecursion Pharmaceuticals	$1.55bn	n/a	n/a
DMRADamora Therapeutics	$1.54bn	n/a	n/a
NRIXNurix Therapeutics	$1.52bn	n/a	n/a
MAZEMaze Therapeutics	$1.51bn	n/a	n/a
AMLXAmylyx Pharmaceuticals	$1.50bn	n/a	n/a
NUVBNuvation Bio	$1.48bn	n/a	n/a
NTLAIntellia Therapeutics	$1.46bn	n/a	n/a